
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | -- | $760.9M | $903.5M | $1.1B | $1.1B | |
Revenue Growth (YoY) | -- | -- | 18.74% | 16.42% | 1.88% | |
Cost of Revenues | -- | $205.6M | $249.5M | $307.8M | $318.8M | |
Gross Profit | -- | $555.3M | $654M | $744M | $752.8M | |
Gross Profit Margin | -- | 72.98% | 72.39% | 70.73% | 70.25% | |
R&D Expenses | -- | $113.8M | $109M | $130.6M | $100.7M | |
Selling, General & Admin | -- | $469.2M | $412.7M | $492M | $389.7M | |
Other Inc / (Exp) | -- | $3.2M | -$129.2M | -$26.5M | -$897.1M | |
Operating Expenses | -- | $690M | $611.5M | $690.6M | $561M | |
Operating Income | -- | -$134.7M | $42.5M | $53.4M | $191.8M | |
Net Interest Expenses | -- | $24.6M | $24.1M | $21.5M | $39.9M | |
EBT. Incl. Unusual Items | -- | -$156.1M | -$110.7M | $5.3M | -$745.2M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -$437.8M | $3.4M | $7.2M | $23.1M | |
Net Income to Company | -- | $281.7M | -$114.1M | -$1.9M | -$768.4M | |
Minority Interest in Earnings | -- | $28.1M | $34.4M | -$2.3M | $211.4M | |
Net Income to Common Excl Extra Items | -- | $309.8M | -$79.7M | -$4.2M | -$557M | |
Basic EPS (Cont. Ops) | -- | $1.50 | -$0.62 | -$0.03 | -$4.61 | |
Diluted EPS (Cont. Ops) | -- | $1.45 | -$0.62 | -$0.03 | -$4.61 | |
Weighted Average Basic Share | $109.4M | $121.4M | $129.4M | $134.9M | $120.8M | |
Weighted Average Diluted Share | $109.4M | $192.7M | $129.4M | $134.9M | $120.8M | |
EBITDA | -- | -$27.6M | $3.1M | $94.9M | -$634.7M | |
EBIT | -- | -$134.7M | -$86.7M | $26.8M | -$705.3M | |
Revenue (Reported) | -- | $760.9M | $903.5M | $1.1B | $1.1B | |
Operating Income (Reported) | -- | -$134.7M | $42.5M | $53.4M | $191.8M | |
Operating Income (Adjusted) | -- | -$134.7M | -$86.7M | $26.8M | -$705.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $170.7M | $210M | $242.9M | $267.8M | $247.1M | |
Revenue Growth (YoY) | -- | 23.03% | 15.67% | 10.22% | -7.72% | |
Cost of Revenues | $47.7M | $55.6M | $70.6M | $81.3M | $73.4M | |
Gross Profit | $123M | $154.4M | $172.4M | $186.5M | $173.7M | |
Gross Profit Margin | 72.03% | 73.52% | 70.95% | 69.64% | 70.32% | |
R&D Expenses | $35M | $27.8M | $33.2M | $36M | $34.5M | |
Selling, General & Admin | $173.4M | $80.7M | $113.4M | $84.5M | $81.4M | |
Other Inc / (Exp) | $7M | $13.2M | -$3.6M | $1.5M | -$10.4M | |
Operating Expenses | $235.4M | $135.4M | $163.3M | $137.7M | $125.5M | |
Operating Income | -$112.4M | $19M | $9.1M | $48.8M | $48.3M | |
Net Interest Expenses | $7.7M | $5.6M | $5.2M | $8.9M | $12M | |
EBT. Incl. Unusual Items | -$113.1M | $26.7M | $284K | $41.3M | $25.8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$436.6M | $2.9M | $2.6M | $7.5M | $6M | |
Net Income to Company | $323.4M | $23.7M | -$2.3M | $33.9M | $19.8M | |
Minority Interest in Earnings | $18.3M | -$7.5M | $718K | -$9.3M | -$6.4M | |
Net Income to Common Excl Extra Items | $341.8M | $16.2M | -$1.6M | $24.6M | $13.4M | |
Basic EPS (Cont. Ops) | $1.74 | $0.13 | -$0.01 | $0.19 | $0.13 | |
Diluted EPS (Cont. Ops) | $1.69 | $0.12 | -$0.01 | $0.19 | $0.13 | |
Weighted Average Basic Share | $115.2M | $129.2M | $131.9M | $128.7M | $105.2M | |
Weighted Average Diluted Share | $191.1M | $191.3M | $131.9M | $128.7M | $105.2M | |
EBITDA | -$85.4M | $45.9M | $25.8M | $67.5M | $47.5M | |
EBIT | -$112.4M | $19M | $9.1M | $50.3M | $37.9M | |
Revenue (Reported) | $170.7M | $210M | $242.9M | $267.8M | $247.1M | |
Operating Income (Reported) | -$112.4M | $19M | $9.1M | $48.8M | $48.3M | |
Operating Income (Adjusted) | -$112.4M | $19M | $9.1M | $50.3M | $37.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $594.5M | $802.4M | $936.4M | $1.1B | $1.1B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $162.9M | $215.7M | $264.5M | $318.5M | $310.9M | |
Gross Profit | $431.6M | $586.8M | $672M | $758.1M | $740.1M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $68.2M | $106.5M | $114.4M | $133.4M | $99.2M | |
Selling, General & Admin | $378.9M | $376.5M | $445.5M | $463.1M | $385M | |
Other Inc / (Exp) | $7.9M | $17.4M | -$146M | -$21.5M | -$910.6M | |
Operating Expenses | $525.4M | $590.1M | $639.4M | $665M | $547.2M | |
Operating Income | -$93.8M | -$3.3M | $32.6M | $93.1M | $192.9M | |
Net Interest Expenses | $17.7M | $22.9M | $23.7M | $25.2M | $43.1M | |
EBT. Incl. Unusual Items | -$103.6M | -$8.8M | -$137.1M | $46.4M | -$760.8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$416M | $2.9M | $3.1M | $12M | $21.7M | |
Net Income to Company | -- | -$18M | -$140.2M | $34.3M | -$782.4M | |
Minority Interest in Earnings | $13.3M | $1M | $42.6M | -$12.3M | $214.2M | |
Net Income to Common Excl Extra Items | $325.7M | -$10.7M | -$72M | $22M | -$568.2M | |
Basic EPS (Cont. Ops) | $1.60 | -$0.07 | -$0.75 | $0.17 | -$4.84 | |
Diluted EPS (Cont. Ops) | $1.55 | -$0.08 | -$0.75 | $0.17 | -$4.84 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -$15.5M | $103.8M | -$17.1M | $143.1M | -$652.5M | |
EBIT | -$93.8M | -$3.3M | -$96.6M | $74.6M | -$715.5M | |
Revenue (Reported) | $594.5M | $802.4M | $936.4M | $1.1B | $1.1B | |
Operating Income (Reported) | -$93.8M | -$3.3M | $32.6M | $93.1M | $192.9M | |
Operating Income (Adjusted) | -$93.8M | -$3.3M | -$96.6M | $74.6M | -$715.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $170.7M | $210M | $242.9M | $267.8M | $247.1M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $47.7M | $55.6M | $70.6M | $81.3M | $73.4M | |
Gross Profit | $123M | $154.4M | $172.4M | $186.5M | $173.7M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $35M | $27.8M | $33.2M | $36M | $34.5M | |
Selling, General & Admin | $173.4M | $80.7M | $113.4M | $84.5M | $81.4M | |
Other Inc / (Exp) | $7M | $13.2M | -$3.6M | $1.5M | -$10.4M | |
Operating Expenses | $235.4M | $135.4M | $163.3M | $137.7M | $125.5M | |
Operating Income | -$112.4M | $19M | $9.1M | $48.8M | $48.3M | |
Net Interest Expenses | $7.7M | $5.6M | $5.2M | $8.9M | $12M | |
EBT. Incl. Unusual Items | -$113.1M | $26.7M | $284K | $41.3M | $25.8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$436.6M | $2.9M | $2.6M | $7.5M | $6M | |
Net Income to Company | $323.4M | $23.7M | -$2.3M | $33.9M | $19.8M | |
Minority Interest in Earnings | $18.3M | -$7.5M | $718K | -$9.3M | -$6.4M | |
Net Income to Common Excl Extra Items | $341.8M | $16.2M | -$1.6M | $24.6M | $13.4M | |
Basic EPS (Cont. Ops) | $1.74 | $0.13 | -$0.01 | $0.19 | $0.13 | |
Diluted EPS (Cont. Ops) | $1.69 | $0.12 | -$0.01 | $0.19 | $0.13 | |
Weighted Average Basic Share | $115.2M | $129.2M | $131.9M | $128.7M | $105.2M | |
Weighted Average Diluted Share | $191.1M | $191.3M | $131.9M | $128.7M | $105.2M | |
EBITDA | -$85.4M | $45.9M | $25.8M | $67.5M | $47.5M | |
EBIT | -$112.4M | $19M | $9.1M | $50.3M | $37.9M | |
Revenue (Reported) | $170.7M | $210M | $242.9M | $267.8M | $247.1M | |
Operating Income (Reported) | -$112.4M | $19M | $9.1M | $48.8M | $48.3M | |
Operating Income (Adjusted) | -$112.4M | $19M | $9.1M | $50.3M | $37.9M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $128M | $369.2M | $402.6M | $355.6M | $204.3M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $41.6M | $47.5M | $66.9M | $102.7M | $99.7M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $6.4M | $11M | $9.2M | $9.8M | $17.1M | |
Other Current Assets | $5.5M | $8.2M | $10.9M | $24.9M | $21.2M | |
Total Current Assets | $251M | $469.5M | $501.4M | $493.1M | $342.2M | |
Property Plant And Equipment | $28.5M | $41M | $31.9M | $27.9M | $19.7M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $1.5B | $1.5B | $1.6B | $1.6B | $1.4B | |
Other Intangibles | $1.8B | $1.7B | $1.5B | $1.5B | $748.9M | |
Other Long-Term Assets | $3.3M | $10M | $31.1M | $7.1M | $11.5M | |
Total Assets | $3.6B | $3.8B | $3.7B | $3.6B | $2.5B | |
Accounts Payable | $23.7M | $19.2M | $3.4M | $4.6M | $6.6M | |
Accrued Expenses | $36.2M | $39.8M | $55.2M | $60.7M | $52.1M | |
Current Portion Of Long-Term Debt | $5.3M | $5.8M | $5.8M | $5.8M | $5.8M | |
Current Portion Of Capital Lease Obligations | $4.9M | $3.9M | $3.1M | $1.2M | $3.1M | |
Other Current Liabilities | $55.1M | $8.8M | $72.8M | $88.5M | $2.6M | |
Total Current Liabilities | $241.3M | $176M | $211.7M | $244.9M | $138.6M | |
Long-Term Debt | $820.9M | $623.2M | $619.2M | $615.2M | $611.3M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $1.6B | $1.3B | $1.2B | $1.3B | $1.2B | |
Common Stock | $1.9B | $1.3M | $1.3M | $1.4M | $1.1M | |
Other Common Equity Adj | $180.9M | $78.6M | $74.5M | $79M | $71.1M | |
Common Equity | $2.1B | $1.6B | $1.6B | $1.6B | $824.5M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $808K | $861.6M | $825.8M | $702.3M | $524.5M | |
Total Equity | $2.1B | $2.5B | $2.5B | $2.3B | $1.3B | |
Total Liabilities and Equity | $3.6B | $3.8B | $3.7B | $3.6B | $2.5B | |
Cash and Short Terms | $128M | $369.2M | $402.6M | $355.6M | $204.3M | |
Total Debt | $826.2M | $629M | $625M | $620.9M | $617.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $246M | $308.8M | $389M | $262.7M | $202.2M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $62.2M | $46.7M | $92.8M | $100.7M | $98.1M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $17.4M | $15.9M | $15.6M | $15.5M | $20.5M | |
Other Current Assets | $6.6M | $8.1M | $11.5M | $15.3M | $17M | |
Total Current Assets | $394.5M | $413.8M | $521M | $394.1M | $337.9M | |
Property Plant And Equipment | $27.1M | $40.9M | $34.4M | $25.7M | $18.8M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $1.5B | $1.6B | $1.6B | $1.6B | $1.4B | |
Other Intangibles | $1.8B | $1.7B | $1.5B | $1.5B | $739M | |
Other Long-Term Assets | $4.3M | $20.1M | $26.5M | $16.7M | $9.6M | |
Total Assets | $3.8B | $3.8B | $3.7B | $3.5B | $2.5B | |
Accounts Payable | $15M | $8.8M | $9.3M | $8.1M | $4.8M | |
Accrued Expenses | $28.2M | $41.6M | $42M | $79.3M | $56.7M | |
Current Portion Of Long-Term Debt | $10M | $2.6M | $5.8M | $5.8M | $5.8M | |
Current Portion Of Capital Lease Obligations | $4.2M | $4.5M | $2.6M | $1.1M | $3.2M | |
Other Current Liabilities | $24.1M | $7.8M | $72.2M | $55.5M | $268K | |
Total Current Liabilities | $201.1M | $166.2M | $208.6M | $201.2M | $119.5M | |
Long-Term Debt | $619.5M | $619.7M | $618.2M | $614.2M | $610.4M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $1.3B | $1.3B | $1.3B | $1.3B | $1.2B | |
Common Stock | $1.4M | $1.3M | $1.4M | $1.4M | $1M | |
Other Common Equity Adj | $178.7M | $79.8M | $76.5M | $76.9M | $120M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $1.1B | $865.9M | $712.5M | $658.9M | $539.7M | |
Total Equity | $2.5B | $2.5B | $2.4B | $2.3B | $1.4B | |
Total Liabilities and Equity | $3.8B | $3.8B | $3.7B | $3.5B | $2.5B | |
Cash and Short Terms | $246M | $308.8M | $389M | $262.7M | $202.2M | |
Total Debt | $629.5M | $622.3M | $624M | $619.9M | $616.1M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | $281.7M | -$114.1M | -$1.9M | -$768.4M | |
Depreciation & Amoritzation | -- | $107.1M | $89.7M | $68M | $70.6M | |
Stock-Based Compensation | -- | $123.9M | $111M | $104.3M | $26.2M | |
Change in Accounts Receivable | -- | -$10M | -$20.7M | -$36M | $5.8M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | $104.8M | $132.9M | $182.1M | $123.4M | |
Capital Expenditures | -- | $13.7M | $16.3M | $14.9M | $26.8M | |
Cash Acquisitions | -- | -- | -$69.7M | -$9.8M | -- | |
Cash From Investing | -- | -$12.5M | -$86.1M | -$24.8M | -$26.8M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -$206.4M | -$5.8M | -$5.8M | -$5.8M | |
Repurchase of Common Stock | -- | -$2B | -- | -$157.1M | -$214.3M | |
Other Financing Activities | -- | -$9.3M | -$9.2M | -$36M | -$30.8M | |
Cash From Financing | -- | $151.5M | -$15M | -$198.9M | -$250.8M | |
Beginning Cash (CF) | -- | $128.3M | $369.2M | $407M | $359.2M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | $243.8M | $31.9M | -$41.6M | -$154.1M | |
Ending Cash (CF) | -- | $369.2M | $402.6M | $355.6M | $204.3M | |
Levered Free Cash Flow | -- | $91.2M | $116.6M | $167.2M | $96.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $323.4M | $23.7M | -$2.3M | $33.9M | $19.8M | |
Depreciation & Amoritzation | $27M | $26.9M | $16.7M | $17.2M | $9.6M | |
Stock-Based Compensation | $45.8M | $17.6M | $28.6M | $26K | $4.1M | |
Change in Accounts Receivable | -$21.1M | $494K | -$26M | $3.6M | -$720K | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$45.6M | $19.4M | $13.4M | $2.4M | $43.2M | |
Capital Expenditures | $2.7M | $5M | $6.8M | $2.8M | $2.4M | |
Cash Acquisitions | -- | -$69.7M | -- | -- | -- | |
Cash From Investing | -$2.7M | -$74.7M | -$6.8M | -$2.8M | -$2.4M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$200M | -$1.4M | -$1.4M | -$1.4M | -$1.4M | |
Repurchase of Common Stock | -$2B | -- | -- | -$84.3M | -$28.7M | |
Other Financing Activities | -- | -$5.7M | -$14.7M | -$8.7M | -$12.3M | |
Cash From Financing | $166.7M | -$7.1M | -$16.2M | -$94.4M | -$42.5M | |
Beginning Cash (CF) | $128M | $369.2M | $407M | $359.2M | $207.1M | |
Foreign Exchange Rate Adjustment | -$162K | $2.1M | -$4.3M | $1.6M | $328K | |
Additions / Reductions | $118.4M | -$62.5M | -$9.6M | -$94.7M | -$1.6M | |
Ending Cash (CF) | $246M | $308.8M | $389M | $262.7M | $202.2M | |
Levered Free Cash Flow | -$48.3M | $14.4M | $6.6M | -$381K | $40.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -$18M | -$140.2M | $34.3M | -$782.4M | |
Depreciation & Amoritzation | -- | $107M | $79.5M | $68.5M | $63M | |
Stock-Based Compensation | $45.8M | $95.6M | $122M | $75.8M | $30.4M | |
Change in Accounts Receivable | -- | $11.6M | -$47.3M | -$6.4M | $1.5M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | $169.8M | $127M | $171.1M | $164.3M | |
Capital Expenditures | $2.7M | $15.9M | $18.1M | $10.9M | $26.4M | |
Cash Acquisitions | -- | -$69.7M | -- | -$9.8M | -- | |
Cash From Investing | -- | -$84.5M | -$18.1M | -$20.7M | -$26.4M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -$7.9M | -$5.8M | -$5.8M | -$5.8M | |
Repurchase of Common Stock | -- | -- | -- | -$241.4M | -$158.7M | |
Other Financing Activities | -- | -- | -$18.2M | -$29.9M | -$34.5M | |
Cash From Financing | -- | -$22.4M | -$24M | -$277.1M | -$198.9M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | $62.9M | $84.8M | -$126.7M | -$61M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | $153.8M | $108.8M | $160.2M | $137.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $323.4M | $23.7M | -$2.3M | $33.9M | $19.8M | |
Depreciation & Amoritzation | $27M | $26.9M | $16.7M | $17.2M | $9.6M | |
Stock-Based Compensation | $45.8M | $17.6M | $28.6M | $26K | $4.1M | |
Change in Accounts Receivable | -$21.1M | $494K | -$26M | $3.6M | -$720K | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$45.6M | $19.4M | $13.4M | $2.4M | $43.2M | |
Capital Expenditures | $2.7M | $5M | $6.8M | $2.8M | $2.4M | |
Cash Acquisitions | -- | -$69.7M | -- | -- | -- | |
Cash From Investing | -$2.7M | -$74.7M | -$6.8M | -$2.8M | -$2.4M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$200M | -$1.4M | -$1.4M | -$1.4M | -$1.4M | |
Repurchase of Common Stock | -$2B | -- | -- | -$84.3M | -$28.7M | |
Other Financing Activities | -- | -$5.7M | -$14.7M | -$8.7M | -$12.3M | |
Cash From Financing | $166.7M | -$7.1M | -$16.2M | -$94.4M | -$42.5M | |
Beginning Cash (CF) | $128M | $369.2M | $407M | $359.2M | $207.1M | |
Foreign Exchange Rate Adjustment | -$162K | $2.1M | -$4.3M | $1.6M | $328K | |
Additions / Reductions | $118.4M | -$62.5M | -$9.6M | -$94.7M | -$1.6M | |
Ending Cash (CF) | $246M | $308.8M | $389M | $262.7M | $202.2M | |
Levered Free Cash Flow | -$48.3M | $14.4M | $6.6M | -$381K | $40.8M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.